These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 16831604

  • 1. S-adenosylmethionine regulates cytoplasmic HuR via AMP-activated kinase.
    Martínez-Chantar ML, Vázquez-Chantada M, Garnacho M, Latasa MU, Varela-Rey M, Dotor J, Santamaria M, Martínez-Cruz LA, Parada LA, Lu SC, Mato JM.
    Gastroenterology; 2006 Jul; 131(1):223-32. PubMed ID: 16831604
    [Abstract] [Full Text] [Related]

  • 2. 5-Aminoimidazole-4-carboxamide riboside suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of phosphatidylinositol 3-kinase/Akt activation in RAW 264.7 murine macrophages.
    Jhun BS, Jin Q, Oh YT, Kim SS, Kong Y, Cho YH, Ha J, Baik HH, Kang I.
    Biochem Biophys Res Commun; 2004 May 28; 318(2):372-80. PubMed ID: 15120611
    [Abstract] [Full Text] [Related]

  • 3. 5-Aminoimidazole-4-carboxamide ribonucleoside stabilizes low density lipoprotein receptor mRNA in hepatocytes via ERK-dependent HuR binding to an AU-rich element.
    Yashiro T, Nanmoku M, Shimizu M, Inoue J, Sato R.
    Atherosclerosis; 2013 Jan 28; 226(1):95-101. PubMed ID: 23116706
    [Abstract] [Full Text] [Related]

  • 4. Evidence for LKB1/AMP-activated protein kinase/ endothelial nitric oxide synthase cascade regulated by hepatocyte growth factor, S-adenosylmethionine, and nitric oxide in hepatocyte proliferation.
    Vázquez-Chantada M, Ariz U, Varela-Rey M, Embade N, Martínez-Lopez N, Fernández-Ramos D, Gómez-Santos L, Lamas S, Lu SC, Martínez-Chantar ML, Mato JM.
    Hepatology; 2009 Feb 28; 49(2):608-17. PubMed ID: 19177591
    [Abstract] [Full Text] [Related]

  • 5. 5-Aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside stimulates tyrosine hydroxylase activity and catecholamine secretion by activation of AMP-activated protein kinase in PC12 cells.
    Fukuda T, Ishii K, Nanmoku T, Isobe K, Kawakami Y, Takekoshi K.
    J Neuroendocrinol; 2007 Aug 28; 19(8):621-31. PubMed ID: 17620104
    [Abstract] [Full Text] [Related]

  • 6. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
    Frau M, Feo F, Pascale RM.
    J Hepatol; 2013 Oct 28; 59(4):830-41. PubMed ID: 23665184
    [Abstract] [Full Text] [Related]

  • 7. Stimulation of hepatocytic AMP-activated protein kinase by okadaic acid and other autophagy-suppressive toxins.
    Samari HR, Møller MT, Holden L, Asmyhr T, Seglen PO.
    Biochem J; 2005 Mar 01; 386(Pt 2):237-44. PubMed ID: 15461583
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression.
    Igata M, Motoshima H, Tsuruzoe K, Kojima K, Matsumura T, Kondo T, Taguchi T, Nakamaru K, Yano M, Kukidome D, Matsumoto K, Toyonaga T, Asano T, Nishikawa T, Araki E.
    Circ Res; 2005 Oct 14; 97(8):837-44. PubMed ID: 16151020
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Implication of S-adenosylhomocysteine hydrolase in inhibition of TNF-alpha- and IL-1beta-induced expression of inflammatory mediators by AICAR in RPE cells.
    Qin S, Ni M, De Vries GW.
    Invest Ophthalmol Vis Sci; 2008 Mar 14; 49(3):1274-81. PubMed ID: 18326758
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of glucokinase translocation by AMP-activated protein kinase is associated with phosphorylation of both GKRP and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.
    Mukhtar MH, Payne VA, Arden C, Harbottle A, Khan S, Lange AJ, Agius L.
    Am J Physiol Regul Integr Comp Physiol; 2008 Mar 14; 294(3):R766-74. PubMed ID: 18199594
    [Abstract] [Full Text] [Related]

  • 14. Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and AICAR.
    Sakamoto K, Göransson O, Hardie DG, Alessi DR.
    Am J Physiol Endocrinol Metab; 2004 Aug 14; 287(2):E310-7. PubMed ID: 15068958
    [Abstract] [Full Text] [Related]

  • 15. AMP-activated protein kinase-independent inhibition of hepatic mitochondrial oxidative phosphorylation by AICA riboside.
    Guigas B, Taleux N, Foretz M, Detaille D, Andreelli F, Viollet B, Hue L.
    Biochem J; 2007 Jun 15; 404(3):499-507. PubMed ID: 17324122
    [Abstract] [Full Text] [Related]

  • 16. AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation.
    Nagata D, Takeda R, Sata M, Satonaka H, Suzuki E, Nagano T, Hirata Y.
    Circulation; 2004 Jul 27; 110(4):444-51. PubMed ID: 15262850
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.